FDA product code OYM: Prostrate Cancer Genes Nucleic Acid Amplification Test System

OYM is the FDA product code for prostrate cancer genes nucleic acid amplification test system. It is a Class III device, reviewed by the Immunology panel. Devices under OYM reach the market by PMA; FDA lists no cleared 510(k)s for it. 1 PMA application cites this product code.

Definition

An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.

Classification

FieldValue
Device nameProstrate Cancer Genes Nucleic Acid Amplification Test System
Device classClass III
Review panelIM — Immunology
Medical specialtyUnknown
Premarket routePMA

Recalls for OYM devices

FDA recall records list no recalls for product code OYM.

Frequently asked questions

What is FDA product code OYM?

OYM is the FDA product code for prostrate cancer genes nucleic acid amplification test system. It is a Class III device, reviewed by the Immunology panel.

What device class is OYM?

Class III. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times